XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (13,802) $ (16,152)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of debt discount and issuance cost 2,132 1,626
Bad debt (recovery) expense 425 166
Loss on settlement of liabilities 3,345 1,363
Changes in deferred tax assets and liabilities 788 (1,477)
Change in allowance for sales returns and volume rebate 1,145 73
Change in inventory reserve 250 155
Change in fair value of derivative liability (13) 216
Shares issued for interest payment on notes payable 617 499
Stock compensation expense 4,060 1,628
Other share-based payments   7
Depreciation and amortization 7,175 2,608
Changes in operating assets and liabilities:    
Accounts receivable - trade (6,427) (212)
Inventories (20,998) 795
Prepaid expenses and other current assets (2,470) (1,994)
Other assets (158) 6
Accounts payable and accrued expenses 18,050 2,176
Other short-term liabilities 344 906
Warranty liability (102) 76
Accounts payable and accrued expenses - related parties   37
Deferred revenues 4,318 2,847
Other liabilities (1,009) (13)
Net cash used in operating activities (2,330) (4,664)
Cash flows from investing activities:    
Business acquisitions (net of cash acquired) (33,604) (45,053)
Cash paid to settle earnout obligations (119)  
Purchases of furniture and fixtures, net (285) (265)
Net cash used in investing activities (34,008) (45,318)
Cash flows from financing activities:    
Proceeds from short-term debt 54,225 10,067
Principal payments on short-term debt (66,912) (8,608)
Discount on notes payable (500)  
Proceeds from convertible debt   20,750
Proceeds from long term debt 58,500  
Debt issuance costs (3,324) (20)
Payments of fixed dividends to Series B Preferred stockholders (1,269) (338)
Proceeds from issuance of common stock 428 42,718
Proceeds from the Payment Protection Plan   1,009
Net cash provided by financing activities 41,148 65,578
Effect of foreign currency exchange rates (332) (3,309)
Net increase in cash and cash equivalents 4,478 12,287
Cash and cash equivalents, beginning of the period 13,460 1,173
Cash and cash equivalents, end of the period 17,938 13,460
Supplemental cash flow disclosures:    
Cash paid for income taxes 1,476 2,316
Cash paid for interest 1,497 542
Non-cash investing and financing transactions:    
Preferred shares issued as consideration for acquisition of Sahara   28,876
Note payable issued as consideration for acquisition of MyStemkits   175
Shares issued to settle accounts payable 1,626 1,372
Shares issued to convert notes payable - Lind Global 17,454 10,499
Shares issued for closing fees related to outstanding notes payable - Lind Global   517
Exercise of warrants 350  
Shares issued for acquisition 403 $ 404
Deemed contribution from Series B Preferred Stock $ 367